RSI Overbought Stocks
AVNS is RSI overbought, meaning strong buying pressure may lead to a short-term consolidation or pullback.
AVANOS MEDICAL INC (AVNS) Stock Price & Overview
NYSE:AVNS • US05350V1061
Current stock price
24.66 USD
+0.04 (+0.16%)
At close:
24.66 USD
0 (0%)
After Hours:
The current stock price of AVNS is 24.66 USD. Today AVNS is up by 0.16%. In the past month the price increased by 76.77%. In the past year, price increased by 100.65%.
AVNS Key Statistics
52-Week Range9.303 - 24.75
Current AVNS stock price positioned within its 52-week range.
1-Month Range13.57 - 24.75
Current AVNS stock price positioned within its 1-month range.
- Market Cap
- 1.147B
- P/E
- 26.23
- Fwd P/E
- 24.15
- EPS (TTM)
- 0.94
- Dividend Yield
- N/A
AVNS Stock Performance
Today
+0.16%
1 Week
N/A
1 Month
+76.77%
3 Months
+85.14%
Longer-term
6 Months +121.96%
1 Year +100.65%
2 Years +23.86%
3 Years +0.65%
5 Years -38.50%
10 Years N/A
AVNS Stock Chart
AVNS Stock Screens
AVNS currently appears in the following ChartMill screener lists.
AVNS Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to AVNS. When comparing the yearly performance of all stocks, AVNS is one of the better performing stocks in the market, outperforming 95.37% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
AVNS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AVNS. AVNS has an average financial health and profitability rating.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AVNS Earnings
On February 24, 2026 AVNS reported an EPS of 0.29 and a revenue of 180.90M. The company beat EPS expectations (14.64% surprise) and beat revenue expectations (1.52% surprise).
Next Earnings DateMay 4, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported$0.29
Revenue Reported180.9M
EPS Surprise 14.64%
Revenue Surprise 1.52%
AVNS Forecast & Estimates
For the next year, analysts expect an EPS growth of 8.62% and a revenue growth 2.16% for AVNS
Analysts
Analysts43.33
Price TargetN/A
EPS Next Y8.62%
Revenue Next Year2.16%
AVNS Index Membership
AVNS is currently included in the following stock indexes tracked on ChartMill.
AVNS Financial Highlights
Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS decreased by -25.4% compared to the year before.
Income Statements
Revenue(TTM)701.20M
Net Income(TTM)-72.90M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.79% | ||
| ROE | -9.37% | ||
| Debt/Equity | 0.12 |
Chartmill High Growth Momentum
EPS Q2Q%-30.95%
Sales Q2Q%0.72%
EPS 1Y (TTM)-25.4%
Revenue 1Y (TTM)1.95%
AVNS Ownership
Ownership
Inst Owners97.14%
Shares46.51M
Float44.41M
Ins Owners4.67%
Short Float %4.51%
Short Ratio1.54
AVNS Industry Overview
AVNS operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
17/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
32/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
27%
Outperformed 27% of sub-industries
3 Month Rank
21%
Outperformed 21% of sub-industries
6 Month Rank
25%
Outperformed 25% of sub-industries
Industry Fundamentals & Breadth
- Members
- 34
- New Highs
- 2.9%
- New Lows
- 14.7%
- Average ROE
- 12.6%
- Average Profit Margin
- 7.9%
- Average Operating Margin
- 10.8%
- Average P/E
- 24.7
- Average Fwd P/E
- 21.6
- Average Debt/Equity
- 0.9
AVNS Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.84 | 58.42B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.27 | 12.606B | ||
| COO | COOPER COS INC/THE | 12.29 | 12.272B | ||
| SOLV | SOLVENTUM CORP | 10.12 | 11.681B | ||
| LNTH | LANTHEUS HOLDINGS INC | 16.14 | 5.498B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 13.84 | 4.067B | ||
| ICUI | ICU MEDICAL INC | 14.37 | 2.979B | ||
| HAE | HAEMONETICS CORP/MASS | 11.19 | 2.792B | ||
| XRAY | DENTSPLY SIRONA INC | 8.09 | 2.347B | ||
| NEOG | NEOGEN CORP | 28.1 | 2.046B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.26 | 1.477B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.305B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVNS
Company Profile
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Company Info
IPO: 2014-10-21
AVANOS MEDICAL INC
5405 Windward Parkway, Suite 100 South
Alpharetta GEORGIA 30004 US
CEO: Joseph F. Woody
Employees: 2287
Phone: 18444282667
AVANOS MEDICAL INC / AVNS FAQ
Can you describe the business of AVANOS MEDICAL INC?
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
What is the current price of AVNS stock?
The current stock price of AVNS is 24.66 USD. The price increased by 0.16% in the last trading session.
Does AVANOS MEDICAL INC pay dividends?
AVNS does not pay a dividend.
What is the ChartMill technical and fundamental rating of AVNS stock?
AVNS has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is AVANOS MEDICAL INC (AVNS) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVNS.
What is the Short Interest ratio of AVANOS MEDICAL INC (AVNS) stock?
The outstanding short interest for AVANOS MEDICAL INC (AVNS) is 4.51% of its float.